Acute Febrile Neutrophilic Dermatosis
- Author: Yoon-Soo (Cindy) Bae, MD; Chief Editor: William D James, MD more...
Acute febrile neutrophilic dermatosis, also termed Sweet syndrome, is a reactive process characterized by the abrupt onset of tender, red-to-purple papules, and nodules that coalesce to form plaques. The plaques usually occur on the upper extremities, face, or neck and are typically accompanied by fever and peripheral neutrophilia.
Described in 1964 by Robert Sweet, the entity currently recognized as Sweet syndrome ranges from classic Sweet disease, which occurs in young women after a mild respiratory illness, to a more aggressive neutrophilic process, which may be associated with other inflammatory diseases or malignancy.[1, 2, 3] In fact, the lesions may be the first evidence of an underlying disorder and should prompt further investigation. A drug-induced variant due to the administration of various medications has been recognized, and a pregnancy-associated form has also been reported.[1, 4, 5, 6]
In general, Sweet syndrome responds dramatically to oral corticosteroids and may improve or resolve with treatment of the underlying condition. Without treatment, the syndrome may persist for weeks or months and then improves without leaving scars. Recurrences are common. In rare cases, crops of lesions reappear and the condition persists indefinitely. Cases associated with malignancy can be bullous or ulcerative and resemble atypical pyoderma gangrenosum. These lesions are often recalcitrant to treatment.[1, 7, 8, 9]
The diagnosis of Sweet syndrome is based on both clinical and histopathologic findings. Characteristics that distinguish the lesions of Sweet syndrome from other neutrophilic dermatosis are healing of the lesions without scarring and an absence of vasculitis. However, recent reports suggest that vasculitis should not exclude the diagnosis since it has been shown to occur in many patients with Sweet syndrome, which may represent an epiphenomenon instead of a primary immune-mediated process.
Acute febrile neutrophilic dermatosis (Sweet syndrome) is a reactive process (a hypersensitivity reaction) that occurs in response to systemic factors, such as hematologic disease, infection, inflammation, vaccination, or drug exposure. The condition is neutrophil mediated, as evidenced by its histopathologic appearance, associated neutrophilia, and response to medications that affect neutrophil activity.
The association of exogenous granulocyte colony-stimulating factors (G-CSF) with the development of Sweet syndrome also supports the importance of neutrophils and related endogenous cytokines in the underlying process. G-CSF suppresses apoptosis and prolongs the survival of neutrophils in vivo in a CD34+ cell population. G-CSF levels in peripheral blood are increased in patients with active Sweet syndrome, suggesting that high levels of G-CSF may one day be a useful indicator of activity level of the disease. The functional properties of neutrophils, rather than the absolute number, is thought to be significant because patients with Sweet syndrome due to G-CSF develop lesions as the neutrophil count rapidly increases, despite the absolute neutrophil count being low.[8, 12, 13] See the Absolute Neutrophil Count calculator.
In addition, some studies have suggested a role for tumor necrosis factor, and others have suggested an imbalance of type 1 helper T cells. Although the skin is the primary organ affected, other systems, most notably the lungs and kidneys, can also be involved. Other reactive neutrophilic disorders, such as neutrophilic eccrine hidradenitis, are closely related and may represent a spectrum with related pathogenesis.
A possible genetic link with HLA-B54 has been observed in the Japanese population. A report of 2 brothers who developed Sweet syndrome in the neonatal period also supports a genetic predisposition. Structural alterations in the long arm of chromosome 3 (3q) have been seen in association with Sweet syndrome; these changes involve genes that affect the regulation of granulopoiesis and neutrophil migration.
Acute febrile neutrophilic dermatosis (Sweet syndrome) is uncommon but not rare. In several series, 10 -20% of cases have occurred in a setting of malignancy, though most are idiopathic or associated with benign conditions.[6, 7]
Acute febrile neutrophilic dermatosis (Sweet syndrome) has no known racial predilection.
The common reactive variant of acute febrile neutrophilic dermatosis (Sweet syndrome) does have a female predominance, with a female-to-male ratio of 15:1. However, this predilection was not noted in series of cases associated with malignancy. No sex predisposition has been observed in children.
Typically, women with acute febrile neutrophilic dermatosis (Sweet syndrome) are aged 30-50 years. However, cases in neonates as young as 5 days have been described. In children, Sweet syndrome is extremely rare and generally associated with infection.
Sweet syndrome occurring in an infant should prompt a workup for immunodeficiency, as well as a review of the peripheral blood smear to rule out the rare case of malignancy.
Cohen PR, Kurzrock R. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol. 2003 Oct. 42(10):761-78. [Medline].
Sweet RD. An Acute Febrile Neutrophilic Dermatosis. Br J Dermatol. 1964 Aug-Sep. 76:349-56. [Medline].
Vignon-Pennamen MD, Juillard C, Rybojad M, Wallach D, Daniel MT, Morel P, et al. Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases. Arch Dermatol. 2006 Sep. 142 (9):1170-6. [Medline].
Cohen PR, Kurzrock R. Sweet's syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol. 2000 May-Jun. 18(3):265-82. [Medline].
Cohen PR. Pregnancy-associated Sweet's syndrome: world literature review. Obstet Gynecol Surv. 1993 Aug. 48(8):584-7. [Medline].
Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol. 1996 May. 34(5 Pt 2):918-23. [Medline].
Callen JP. Neutrophilic dermatoses. Dermatol Clin. 2002 Jul. 20(3):409-19. [Medline].
Arbetter KR, Hubbard KW, Markovic SN, Gibson LE, Phyliky RL. Case of granulocyte colony-stimulating factor-induced Sweet's syndrome. Am J Hematol. 1999 Jun. 61(2):126-9. [Medline].
Dereure O, Hillaire-Buys D, Guilhou JJ. Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome?. Br J Dermatol. 2004 Jun. 150(6):1228-30. [Medline].
Malone JC, Slone SP, Wills-Frank LA, et al. Vascular inflammation (vasculitis) in sweet syndrome: a clinicopathologic study of 28 biopsy specimens from 21 patients. Arch Dermatol. 2002 Mar. 138(3):345-9. [Medline].
Carpentier O, Piette F, Delaporte E. Sweet's syndrome after BCG vaccination. Acta Derm Venereol. 2002. 82(3):221. [Medline].
Kawakami T, Ohashi S, Kawa Y, et al. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol. 2004 May. 140(5):570-4. [Medline].
Kumar G, Bernstein JM, Waibel JS, Baumann MA. Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment. Am J Hematol. 2004 Jul. 76(3):283-5. [Medline].
Parsapour K, Reep MD, Gohar K, Shah V, Church A, Shwayder TA. Familial Sweet's syndrome in 2 brothers, both seen in the first 2 weeks of life. J Am Acad Dermatol. 2003 Jul. 49(1):132-8. [Medline].
Tuerlinckx D, Bodart E, Despontin K, Boutsen Y, Godding V, Ninane J. Sweet's syndrome with arthritis in an 8-month-old boy. J Rheumatol. 1999 Feb. 26(2):440-2. [Medline].
Bourke JF, Keohane S, Long CC, et al. Sweet's syndrome and malignancy in the U.K. Br J Dermatol. 1997 Oct. 137(4):609-13. [Medline].
Boatman BW, Taylor RC, Klein LE, Cohen BA. Sweet's syndrome in children. South Med J. 1994 Feb. 87(2):193-6. [Medline].
Barr KL, O' Connell F, Wesson S, Vincek V. Nonbullous neutrophilic dermatosis: Sweet's syndrome, neonatal lupus erythematosus, or both?. Mod Rheumatol. 2009. 19(2):212-5. [Medline].
Cohen PR. Skin lesions of Sweet syndrome and its dorsal hand variant contain vasculitis: an oxymoron or an epiphenomenon?. Arch Dermatol. 2002 Mar. 138(3):400-3. [Medline].
Crum NF, Higginbottom PA, Fehl FC, Graham BS. Sweet's syndrome masquerading as facial cellulitis. Cutis. 2003 Jun. 71(6):469-72. [Medline].
Saliba WR, Goldstein LH, Habib GS, Elias MS. Sweet's syndrome affecting the external auditory canal and tympanic membrane. J Laryngol Otol. 2004 Jan. 118(1):48-9. [Medline].
Owen CE, Malone JC, Callen JP. Sweet-like dermatosis in 2 patients with clinical features of dermatomyositis and underlying autoimmune disease. Arch Dermatol. 2008 Nov. 144(11):1486-90. [Medline].
Walling HW, Snipes CJ, Gerami P, Piette WW. The relationship between neutrophilic dermatosis of the dorsal hands and sweet syndrome: report of 9 cases and comparison to atypical pyoderma gangrenosum. Arch Dermatol. 2006 Jan. 142(1):57-63. [Medline].
Levy J, Schneck M, Erlich Y, Lifshitz T. Sweet's syndrome presenting as acute episcleritis. Can J Ophthalmol. 2005 Feb. 40(1):90-2. [Medline].
Kato T, Kawana S, Takezaki S, Kikuchi S, Futagami A. Case of Sweet's syndrome with extensive necrosis and ulcers accompanied by myelodysplastic syndrome. J Nippon Med Sch. 2008 Jun. 75(3):162-5. [Medline].
Song WK, Bang D, Choi YJ, Lee SC, Oh SH. Sudden visual loss due to occlusive venous vasculitis associated with Sweet syndrome. Arch Dermatol. 2009 Feb. 145(2):216-8. [Medline].
Astudillo L, Sailler L, Launay F, et al. Pulmonary involvement in Sweet's syndrome: a case report and review of the literature. Int J Dermatol. 2006 Jun. 45(6):677-80. [Medline].
DiCaudo DJ, Ortiz KJ, Mengden SJ, Lim KK. Sweet syndrome (acute febrile neutrophilic dermatosis) associated with pulmonary coccidioidomycosis. Arch Dermatol. 2005 Jul. 141(7):881-4. [Medline].
Robbins CM, Mason SE, Hughey LC. Sweet syndrome with pulmonary involvement in a healthy young woman. Arch Dermatol. 2009 Mar. 145(3):344-6. [Medline].
Hospach T, von den Driesch P, Dannecker GE. Acute febrile neutrophilic dermatosis (Sweet's syndrome) in childhood and adolescence: two new patients and review of the literature on associated diseases. Eur J Pediatr. 2009 Jan. 168(1):1-9. [Medline].
Fain O, Mathieu E, Feton N, et al. Intestinal involvement in Sweet's syndrome. J Am Acad Dermatol. 1996 Dec. 35(6):989-90. [Medline].
Levin J, Werth VP. Skin disorders with arthritis. Best Pract Res Clin Rheumatol. 2006 Aug. 20(4):809-26. [Medline].
Bayer-Garner IB, Cottler-Fox M, Smoller BR. Sweet syndrome in multiple myeloma: a series of six cases. J Cutan Pathol. 2003 Apr. 30(4):261-4. [Medline].
Shinojima Y, Toma Y, Terui T. Sweet syndrome associated with intrahepatic cholangiocarcinoma producing granulocyte colony-stimulating factor. Br J Dermatol. 2006 Nov. 155(5):1103-4. [Medline].
Dorenkamp M, Weikert U, Meyer R, Schwimmbeck PL, Morguet AJ. Heart failure in acute febrile neutrophilic dermatosis. Lancet. 2003 Oct 25. 362(9393):1374. [Medline].
Marie I, Levesque H, Joly P, et al. Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis. J Am Acad Dermatol. 2001 Jan. 44(1):137-9. [Medline].
Quilichini R, Mazzerbo F, Baume D, Carsuzaa F, Burtey S. [Sweet's syndrome and aseptic abscess of the spleen]. Rev Med Interne. 1996. 17(12):1029-31. [Medline].
Alper Y, Sprecher E, Bergman R, Birnbaum RF. Sweet's syndrome-like neutrophilic dermatosis resulting from exposure to a radiocontrast agent. J Am Acad Dermatol. 2008 Mar. 58(3):488-9. [Medline].
Shugarman IL, Schmit JM, Sbicca JA, Wirk B. Easily missed extracutaneous manifestation of malignancy-associated Sweet's syndrome: systemic inflammatory response syndrome. J Clin Oncol. 2011 Aug 20. 29(24):e702-5. [Medline].
Otheo E, Ros P, Vázquez JL, et al. Systemic inflammatory response syndrome associated with Sweet's syndrome. Pediatr Crit Care Med. 2002 Apr. 3(2):190-193. [Medline].
Sawicki J, Morton RA, Ellis AK. Sweet syndrome with associated systemic inflammatory response syndrome: an ultimately fatal case. Ann Allergy Asthma Immunol. 2010 Oct. 105(4):321-3. [Medline].
Timmer-DE Mik L, Broekhuijsen-VAN Henten DM, Oldhoff JM, DE Geer DB, Sigurdsson V, Pasmans SG. Acquired cutis laxa in childhood Sweet's syndrome. Pediatr Dermatol. 2009 May-Jun. 26(3):358-60. [Medline].
Guhamajumdar M, Agarwala B. Sweet syndrome, cutis laxa, and fatal cardiac manifestations in a 2-year-old girl. Tex Heart Inst J. 2011. 38(3):285-7. [Medline].
Hisanaga K, Iwasaki Y, Itoyama Y. Neuro-Sweet disease: clinical manifestations and criteria for diagnosis. Neurology. 2005 May 24. 64(10):1756-61. [Medline].
Nobeyama Y, Kamide R. Sweet's syndrome with neurologic manifestation: case report and literature review. Int J Dermatol. 2003 Jun. 42(6):438-43. [Medline].
Fett DL, Gibson LE, Su WP. Sweet's syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc. 1995 Mar. 70(3):234-40. [Medline].
von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994 Oct. 31(4):535-56; quiz 557-60. [Medline].
Ayirookuzhi SJ, Ma L, Ramshesh P, Mills G. Imatinib-induced sweet syndrome in a patient with chronic myeloid leukemia. Arch Dermatol. 2005 Mar. 141(3):368-70. [Medline].
Melinkeri SR, Gupta RK, Dabadghao S. A Sweet-like syndrome manifesting as gingival hyperplasia and myositis without cutaneous involvement. Ann Hematol. 2002 Jul. 81(7):397-8. [Medline].
Dereure O, Ebrard-Charra S, Guillon F, Baldet P, Guilhou JJ. Sweet's syndrome associated with pheochromocytoma. Dermatology. 2004. 208(2):175. [Medline].
Loehberg L, Simon M. Sweets syndrome: a rare first cutaneous diagnostic sign in cervical cancer. Eur J Dermatol. 2009 Jan-Feb. 19(1):87-8. [Medline].
Neoh CY, Tan AW, Ng SK. Sweet's syndrome: a spectrum of unusual clinical presentations and associations. Br J Dermatol. 2007 Mar. 156(3):480-5. [Medline].
Polat M, Mualla P, Parlak AH, et al. Erythema nodosum and Sweet's syndrome in patients with glandular tularemia. Int J Dermatol. 2011 Jul. 50(7):866-9. [Medline].
Freitas DF, Valle AC, Cuzzi T, et al. Sweet syndrome associated with sporotrichosis. Br J Dermatol. 2012 Jan. 166(1):212-3. [Medline].
Oskay T, Karademir A, Kutluay L. Sweet's syndrome associated with cytomegalovirus infection. Int J Dermatol. 2004 Jan. 43(1):57-9. [Medline].
Fortna RR, Toporcer M, Elder DE, Junkins-Hopkins JM. A case of sweet syndrome with spleen and lymph node involvement preceded by parvovirus B19 infection, and a review of the literature on extracutaneous sweet syndrome. Am J Dermatopathol. 2010 Aug. 32(6):621-7. [Medline].
Escallier F, Gaudard S, Courtois JM, Dalac S, Collet E, Lambert D. [Sweet's syndrome and Yersinia enterocolitica infection]. Ann Dermatol Venereol. 1990. 117(11):858-60. [Medline].
Kemmett D, Hunter JA. Sweet's syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol. 1990 Sep. 23(3 Pt 1):503-7. [Medline].
Hamill M, Bowling J, Vega-Lopez F. Sweet's syndrome and a Mirena intrauterine system. J Fam Plann Reprod Health Care. 2004 Apr. 30(2):115-6. [Medline].
Hoverson AR, Davis MD, Weenig RH, Wolanskyj AP. Neutrophilic dermatosis (Sweet syndrome) of the hands associated with lenalidomide. Arch Dermatol. 2006 Aug. 142(8):1070-1. [Medline].
Knoops L, Jacquemain A, Tennstedt D, Theate I, Ferrant A, Van den Neste E. Bortezomib-induced Sweet syndrome. Br J Haematol. 2005 Oct. 131(2):142. [Medline].
Smith KJ, Skelton H. Acute onset of neutrophilic dermatosis in patients after therapy with a COX-2-specific inhibitor. Int J Dermatol. 2003 May. 42(5):389-93. [Medline].
El-Azhary RA, Brunner KL, Gibson LE. Sweet syndrome as a manifestation of azathioprine hypersensitivity. Mayo Clin Proc. 2008 Sep. 83(9):1026-30. [Medline].
Jovanovic M, Poljacki M, Vujanovic L, Duran V. Acute febrile neutrophilic dermatosis (Sweet's syndrome) after influenza vaccination. J Am Acad Dermatol. 2005 Feb. 52(2):367-9. [Medline].
Alencar C, Abramowtiz M, Parekh S, et al. Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors. Am J Hematol. 2009 Oct. 84(10):688-9. [Medline].
Rondina A, Watson AC. Bullous Sweet's syndrome and pseudolymphoma precipitated by IL-2 therapy. Cutis. 2010 Apr. 85(4):206-13. [Medline].
Kandula S, Burke WS, Goldfarb JN. Clindamycin-induced Sweet syndrome. J Am Acad Dermatol. 2010 May. 62(5):898-900. [Medline].
Kümpfel T, Gerdes LA, Flaig M, Hohlfeld R, Wollenberg A. Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosis. Mult Scler. 2011 Apr. 17(4):495-7. [Medline].
Rappaport A, Shaked M, Landau M, Dolev E. Sweet's syndrome in association with Crohn's disease: report of a case and review of the literature. Dis Colon Rectum. 2001 Oct. 44(10):1526-9. [Medline].
Oskay T, Anadolu R. Sweet's syndrome in familial Mediterranean fever: possible continuum of the neutrophilic reaction as a new cutaneous feature of FMF. J Cutan Pathol. 2009 Aug. 36(8):901-5. [Medline].
Propst DA, Bossons CR, Sutterlin CE 3rd. Sweet's syndrome associated with spinal surgical intervention. A case report. Spine (Phila Pa 1976). 1998 Aug 1. 23(15):1708-10. [Medline].
Dadban A, Hirschi S, Sanchez M, Lagrange B. Association of Sweet's syndrome and acute sarcoidosis: report of a case and review of the literature. Clin Exp Dermatol. 2009 Mar. 34(2):189-91. [Medline].
Nakayama H, Shimao S, Hamamoto T, Munemura C, Nakai A. Neutrophilic dermatosis of the face associated with aortitis syndrome and Hashimoto's thyroiditis. Acta Derm Venereol. 1993 Oct. 73(5):380-1. [Medline].
Tabache F, El Kartouti A, Abdelilah T, et al. Systemic lupus erythematosus revealed by sweet syndrome. Joint Bone Spine. 2011 Jul. 78(4):420-1. [Medline].
Mahajan VK, Sharma NL, Sharma RC. Sweet's syndrome from an Indian perspective: a report of four cases and review of the literature. Int J Dermatol. 2006 Jun. 45(6):702-8. [Medline].
Tursen U, Bocekli E, Kaya TI, Dusmez D, Ikizoglu G. Sweet's syndrome in a woman with a prothrombin gene (G20210A) mutation. Int J Dermatol. 2002 Sep. 41(9):596-7. [Medline].
Osband AJ, Laskow DA, Mann RA, Berkowicz T, Ianosi-Irimie M, Boruchoff S. Sweet syndrome after kidney transplantation. Transplant Proc. 2009 Jun. 41(5):1954-6. [Medline].
Haddow LJ, Lehloenya R, Mosam A, Malaka S, Moosa MY. Sweet syndrome: adverse drug reaction or novel manifestation of HIV-associated immune reconstitution inflammatory syndrome?. J Am Acad Dermatol. 2011 Jul. 65(1):e23-5. [Medline].
Su WP, Liu HN. Diagnostic criteria for Sweet's syndrome. Cutis. 1986 Mar. 37(3):167-74. [Medline].
Ayoub N, Charuel JL, Diemert MC, et al. Antineutrophil cytoplasmic antibodies of IgA class in neutrophilic dermatoses with emphasis on erythema elevatum diutinum. Arch Dermatol. 2004 Aug. 140(8):931-6. [Medline].
Krug B, Sonet A, Pirson AS, Mahy N, Bosly A, Borght TV. FDG PET utility in paraneoplastic sweet syndrome. Clin Nucl Med. 2004 Feb. 29(2):91-2. [Medline].
Vignon-Pennamen MD, Aractingi S. Sweet's syndrome and leukemia cutis: a common skin homing mechanism?. Dermatology. 2003. 206(2):81-4. [Medline].
Jeanfils S, Joly P, Young P, Le Corvaisier-Pieto C, Thomine E, Lauret P. Indomethacin treatment of eighteen patients with Sweet's syndrome. J Am Acad Dermatol. 1997 Mar. 36(3 Pt 1):436-9. [Medline].
Maillard H, Leclech C, Peria P, Avenel-Audran M, Verret JL. Colchicine for Sweet's syndrome. A study of 20 cases. Br J Dermatol. 1999 Mar. 140(3):565-6. [Medline].
Amouri M, Masmoudi A, Ammar M, Boudaya S, Khabir A, Boudawara T, et al. Sweet's syndrome: a retrospective study of 90 cases from a tertiary care center. Int J Dermatol. 2016 Mar 9. [Medline].
Aram H. Acute febrile neutrophilic dermatosis (Sweet's syndrome). Response to dapsone. Arch Dermatol. 1984 Feb. 120(2):245-7. [Medline].
Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg. 2004 Mar-Apr. 8(2):77-89. [Medline].
Haliasos E, Soder B, Rubenstein DS, Henderson W, Morrell DS. Pediatric Sweet syndrome and immunodeficiency successfully treated with intravenous immunoglobulin. Pediatr Dermatol. 2005 Nov-Dec. 22(6):530-5. [Medline].
Yamauchi PS, Turner L, Lowe NJ, Gindi V, Jackson JM. Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol. 2006 Mar. 54(3 Suppl 2):S122-6. [Medline].
Ambrose NL, Tobin AM, Howard D. Etanercept treatment in Sweet's syndrome with inflammatory arthritis. J Rheumatol. 2009 Jun. 36(6):1348-9. [Medline].
Browning CE, Dixon JE, Malone JC, Callen JP. Thalidomide in the treatment of recalcitrant Sweet's syndrome associated with myelodysplasia. J Am Acad Dermatol. 2005 Aug. 53(2 Suppl 1):S135-8. [Medline].
Kluger N, Gil-Bistes D, Guillot B, Bessis D. Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret®) in a case of refractory Sweet's syndrome. Dermatology. 2011. 222(2):123-7. [Medline].
Hashemi SM, Fazeli SA, Vahedi A, Golabchifard R. Rituximab for refractory subcutaneous Sweet's syndrome in chronic lymphocytic leukemia: A case report. Mol Clin Oncol. 2016 Mar. 4 (3):436-440. [Medline].